According to the website of Food Standards Australia New Zealand (FSANZ), on November 8, 2021, FSANZ issued a notification circular 177-21, approving the application A1190, which permits 2'-fucosyllactose (2'-FL), produced by microbial fermentation using genetically modified Escherichia coli (E.coli) strains, in infant formula products, follow-on formula and formulated supplementary foods for young children (FSFYC).